Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure

Sponsor
Institut de Recherches Internationales Servier (Other)
Overall Status
Completed
CT.gov ID
NCT00202579
Collaborator
(none)
12
1
17
0.7

Study Details

Study Description

Brief Summary

To evaluate the effects on heart function of ivabradine administered to patients with severe chronic heart failure

Condition or Disease Intervention/Treatment Phase
Phase 2

Study Design

Study Type:
Interventional
Anticipated Enrollment :
12 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Official Title:
Evaluation of the Effects on Peripheral and Central Haemodynamics Parameters, Safety, and Tolerance of Three-hour Intravenous Perfusion (0.1 mg/kg) of Ivabradine Given to Severe Congestive Heart Failure Patients
Study Start Date :
Sep 1, 2004
Actual Study Completion Date :
Feb 1, 2006

Outcome Measures

Primary Outcome Measures

  1. Haemodynamic parameters []

  2. Twelve-lead ECG []

  3. Systolic and diastolic blood pressure []

Secondary Outcome Measures

  1. Echocardiography []

  2. Neurohormones []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • systolic congestive heart failure

  • sinus rhythm, HR >= 80bpm

Exclusion Criteria:
  • unstable cardiovascular condition

Contacts and Locations

Locations

Site City State Country Postal Code
1 Policlinico San Matteo Pavia Italy 27100

Sponsors and Collaborators

  • Institut de Recherches Internationales Servier

Investigators

  • Study Chair: Luigi Tavazzi, Pr, Policlinico San Matteo

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00202579
Other Study ID Numbers:
  • CL2-16257-053
First Posted:
Sep 20, 2005
Last Update Posted:
Mar 15, 2018
Last Verified:
Mar 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 15, 2018